Term
What is the difference between acute and chronic intestinal failure? |
|
Definition
Intestinal failure is the impairment of absorptive capacity, needing prolonged fluid/nutrition support to maintain health
Acute - days-weeks; during chemo or radiation therapy
Chronic - Months to years
Short Bowel Syndrome:
Up to 50% of bowel can be removevd with no consequences, SBS usually occurs after surgical resections, thrombosis resulting in intestinal infarction, malignancy, or volvulus |
|
|
Term
What are the most frequent disease states leading to chronic intestinal failure? |
|
Definition
|
|
Term
What are the five factors that affect the severity of short bowel syndrome? |
|
Definition
- Extent of the resection --> <80% is best
- Site --> Jejunum resection is best (Ileum can take over a lot of functions)
- Concomittant Disease --> No disease is best of course
- Duration --> > one year (what?)
- Antatomy of GI tract --> Presence of ileocecal valve and colon. Valve stops food from moving backwards, and colon helps reabsorb electrolytes and fluids |
|
|
Term
What is signficant regarding home parenteral nutrition for the management of gut failure? |
|
Definition
- We want site to be at jejunem, so removing it doesn't affect too much, also want presence of ileocecal valve and colon, so bacteria doesn't infect GI tract.
- If jejunum was removed, and remaining length is <120cm and no colon, give TPN. If jejunum removed and there IS colon, give TPN but <60cm is adequate.
- Adaptation can occur as early as 1-2 days after resection, could take 1-2 YEARS, so keep giving nutrients
- Colon is needed for water/electrolyte exchange |
|
|
Term
What are the strategies for the management of chronic intestinal failure (surgery and nutrition)? |
|
Definition
- Long term/home nutrition support: enteral, parenteral, or both
Surgery makes you shed a TEAR
- Transplantation
- End-end lengthening procedures
- Antiperistaltic segments
- Recirculating loops |
|
|
Term
Which motility agents are available in the management of short bowel syndrome patients to reduce GI output? |
|
Definition
Two types of individuals: Absorbers and Secretors
Absorbers - Take in more nutrients/fluids than they lose, managed by po nutrient/electrolyte support
Secretors - Have more output than intake (usually <100cm intestine remaining), absorb only 35% of po, NEED IV SUPPORT
- Codeine and loperamide are motility agents
- 15-30mg of codeine 30 min. before meals, reduces motility and secretions
- 4mg of loperamide 30 min. before meals, may need to break open capsules so they are absorbed
- H2 blockers or PPI's may also reduce gastric acid production and reduce overall fluid loss. |
|
|
Term
Which is significant regarding octreotide, which is available in the management of short bowel syndrome patients to reduce GI output? |
|
Definition
- Octreotide (Sandostatin)
- Octapeptide of endogenous somatostatin
- Blocks release of serotonin and other peptides like glucagon, gastrin, VIP, and insulin
- Increases Na and water reabsorption, so dec. diarrhea
- Start at 50mcg bid, then titrate upwards to 500mcg q8h
- IM sandostatin is NOT for this same indication
- Dose 10mcg/kg/dose or IV q12h
- ADR's: short term n/v, diarrhea, abd. pain, long term gallstones
- Suppresses tropic stimulation so avoid in early post-resection patients
- May reduce fat abs. messes with blood sugar, flushing, lightheadedness, headache |
|
|
Term
Which is significant regarding cholestyramine, which is available in the management of short bowel syndrome patients to reduce GI output? |
|
Definition
nAbsorbs bile salts which irritate colon
nMay be useful in choleretic (bile salt induced-green color) diarrhea if the ileal resection is <100cm and fecal fat <20g/d (Normal 6g/day).
nIf ileal resection is > 100cm, is usually ineffective and may worsen fat malabsorption(leading to steattorhea) if the bile salt pool is depleted
nDose: 4g qd or bid up to 24g/day before meals and at bedtime
nSide effects: constipation, nausea, vomiting, abdo distension and pain, malabsorption of fat soluble vitamins, blocks feeding tubes
nDrug interactions: avoid other meds 1h before and 4-6h after
nCommon interactions: digoxin, warfarin, thiazides, propranolol
|
|
|
Term
Which is significant regarding growth hormone, which is available in the management of short bowel syndrome patients to reduce GI output? |
|
Definition
- Stimulates bowel adaption, may be combined with glutamine, enhances nutrient absorption
- Dose 0.1mg/kg/day sc for four weeks in PN patients who are stable and have optimal diet and medication therapy 6-24 months after bowel resection
- Timing and appropriateness remains controversial |
|
|
Term
Which is significant regarding glutamine, which is available in the management of short bowel syndrome patients to reduce GI output? |
|
Definition
- 2-4g/day
- may enhance GI mucosal integrity and improve the health of the enterocyte, thereby improving absorption |
|
|
Term
What are the medication delivery issues in SBS patients? |
|
Definition
- How do we know drug is being absorbed?
- need to know PK of the drug, part of intestine that needs to absorb it
- Rectal administration no good, as patient has diarrhea
- length of intestine, mucosal integrity, intestinal motility all plays a role
- Fat soluble or water soluble drug
- Physiological req. for abs.; Acidic (penicillin, ketoconazole), alkaline (procainamide, nitrofurantoin), bile acids needed (Cyclosporin A, D2, squinavir), ileal absorption (B12)
- Patient has low protein stores which can effect drug delivery
- No slow or timed release formulations, caution with EC, parenteral is an option, aerosol, topical. |
|
|
Term
What pathophysiologic effects does SBS have on carbohydrates, fats, and proteins? |
|
Definition
- Once nutrients are absorbed they are handled normally
- Carb malabsorption leads to diarrhea (lactose intolerance)
- For protein absorption, peptides are more easily absorbed than free amino acids
- Fat absorbption most affected in SBS
- Impaired bile salt recycling may lead to gallstones
- Fat can be provided as MCT, but needs LCT b/c we need essential fatty acids as well |
|
|
Term
What pathophysiologic effects does SBS have on fluids and electrolytes? |
|
Definition
- If dehydrated a patient will develop metabolic alkalosis and excrete more K+
- In jejunostomy patients with output of 1.5-21 (is this second number right?), give high NA solution (120meq/glucose 110mmol), low Na draw water out of people
- K+ replacement is only needed if jejunum <50cm and ostomy is present)
- Urine with Na <5meq/L is indicative of Na depletion
- Avoid tea, coffee, water
- Avoid liquids 30 min. before and after meals
- D2 can cure magnesium deficiency, 1-4g of calcium/day should fix this deficiency |
|
|
Term
What pathophysiologic effects does SBS have on acid-base balance? |
|
Definition
- Normal pH 7.4
- H+ and Cl- are lost in ostomy, diarrhea, urine losses
- If colon is present but diarrhea is still there, K+ and HcO3 will be lost, leading to metabolic acidosis |
|
|
Term
What pathophysiologic effects does SBS have on trace element absorption in the Duodenum, Jejunum, Ileum, Terminal Ileum, Colon? |
|
Definition
Duodenum - Calcium, Iron, CHO, fat, Mg, protein
Jejunum - CHO, fat, AA, Mg, copper, zinc, folate, Phosphorous
Ileum - Fat, Mg, Protein, Phosphorous
Terminal Ileum - B12, bile salts
Colon - Water and electrolytes |
|
|
Term
What pathophysiologic effects does SBS have on vitamins? |
|
Definition
- Most water soluble vitamins absorbed in the jejunum so not usually a problem
- If ileal resection >60cm, need B12
- If there is fat malabsorption then we need fat soluble vitamins (ADEK)
- Aqueous form of Vitamin E in PEG may have better absorption po in SBS
- Folate and B12 deficiency can lead to anemia |
|
|
Term
What are some short term complications associated with SBS? |
|
Definition
Hypovolemia --> Increase fluids intake
Hypervolemia --> decrease fluids, diuretics
Hyponatremia --> Replace Na when indicated, diuresis prn
Hypernatremia - Rehydrate as needed, check for sources of Na
Hypokalemia --> Increase K+ intake
Hyperkalemia --> Check sources of K+, correct acidosis
Hypophosphotemia --> Increase P intake, d/c binders
Hyperphosphotemia --> Decrease P intake
Hypomagnesemia --> Increase Mg intake
Hypermagnesemia --> Decrease Mg intake
Hyperglycemia --> Reduce dextrose load, give insulin
Hypoglycemia --> Taper infusion, increase dextrose load
Resp. Acidosis --> Dec. dextrose, inc. fat kcal
Elevated chol. and triglycerides --> dec. fat or d/c if TG>300
Abnormal LFT, raised ALP, AST, Bili --> Decrease kcal, dex., provide essential FA's
Altered AA profile --> Change solution or decrease AA intake |
|
|
Term
What are some altered nutritional requirements in patients with acute renal failure as well? |
|
Definition
- Hyperglycemia and insulin resistance is common
- Hyperkalemia
- Increased serum P and Mg
- Zinc and Copper removed via dialysis, as well as WS vitamins
- Use concentrated macronutrient solutions, keep TG's below 300 |
|
|
Term
What are some altered nutritional requirements in patients with chronic renal failure as well? |
|
Definition
- Less likely than ARF to develop glycemic problems
- Protein req. depend on dialysis
- Na is often low --> control with dialysis
- K+ usually high
- WS vits are decreased, FS are ok, vitamin A may be high |
|
|
Term
What are some altered nutritional requirements in patients with hepatic failure as well? |
|
Definition
- Insulin resis. is common
- TG are elevated
- Aromatic AA accumulate
- Branched AA decrease b/c of metabolism by skeletal muscle
- Na and water retention is common
- K+ and Mg is decreased
- Zinc --> lost in diarrhea
- Copper and Manganese not excreted --> should be held |
|
|
Term
What are some altered nutritional requirements in patients with pulmonary failure as well? |
|
Definition
- Hypermetabolism common in COPD
- Formula should be 60% fat, need to keep glucose load moderate to low as metabolism can lead to dioxide production which is difficult to excrete with lung issues
- Avoid over-feeding
- Keep patient slightly dry
- Make sure serum phosphate is adequate |
|
|